Search

ResMed Inc

Chiusa

SettoreSettore sanitario

226.59 -0.76

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

225

Massimo

229.33

Metriche Chiave

By Trading Economics

Entrata

1.1B

1.5B

Vendite

32M

1.5B

P/E

Media del settore

21.38

56.432

EPS

2.95

Rendimento da dividendi

1.1

Margine di Profitto

104.075

Dipendenti

11,370

EBITDA

-91M

493M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+5.22% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

1.10%

2.27%

Utili prossimi

29 ott 2026

Prossima data del Dividendo

24 set 2026

Prossima data del' Ex Dividendo

12 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

952M

32B

Apertura precedente

227.35

Chiusura precedente

226.59

Notizie sul Sentiment di mercato

By Acuity

43%

57%

110 / 339 Classifica in Healthcare

ResMed Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

16 set 2026, 21:31 UTC

ResMed Inc. is seeing a modest increase in after-hours trading, reaching a peak return of 0.46% following Wednesday's close.

15 set 2026, 22:02 UTC

Social Media

RBC Capital upgraded ResMed Inc to Outperform and raised its price target to $262, with shares trading roughly flat in after-market hours.

9 set 2026, 20:07 UTC

Resmed Inc. shares are lower today amid broader market declines and inflationary pressures tied to rising crude oil prices and interest rate hike speculation.

8 set 2026, 20:02 UTC

News

Resmed Inc shares are lower amid a broader decline in the Health Care Equipment sector, reflecting six consecutive sessions of lower closes.

4 set 2026, 19:47 UTC

Resmed Inc shares are lower, continuing a recent downward trend. No specific news explains today's price movement amid rising Treasury yields and unchanged unemployment figures.

3 set 2026, 22:16 UTC

Resmed Inc. remains roughly flat in after-market trading, with no specific news identified. The stock has faced recent pressure, finishing lower in the last three sessions.

2 set 2026, 20:08 UTC

Resmed Inc. shares are lower today, reflecting broader market declines since Tuesday. The ADP report indicates slower job growth, impacting Federal Reserve rate considerations.

1 set 2026, 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

31 ago 2026, 20:07 UTC

ResMed Inc shares are lower today, influenced by Fed officials' comments on inflation and interest rates. Earlier, shares briefly recovered above Friday's close.

28 ago 2026, 20:07 UTC

News

Resmed Inc shares are higher today, reaching a session high and exceeding their 20-day moving average amid rising U.S. Treasury yields and inflation concerns.

27 ago 2026, 19:36 UTC

Social Media

Resmed Inc's shares are lower amid concerns over its MatrixCare divestiture, which reflects a significant drop in valuation from its 2018 acquisition.

26 ago 2026, 20:07 UTC

Resmed Inc shares are lower today, influenced by a decline in the Health Care Equipment sub-sector. No specific company news was identified.

25 ago 2026, 23:36 UTC

Shares of Resmed Inc. rose in after-market trading, continuing an upward trend since Tuesday's close despite earlier declines. The stock remains above its 20-day moving average.

24 ago 2026, 23:56 UTC

Resmed Inc. shares are lower in after-market hours amid weak trading sentiment. No specific company news was identified to explain the decline.

21 ago 2026, 20:06 UTC

ResMed Inc shares are higher today, reflecting broader market trends. The stock remains above its 20-day moving average and near its one-month range.

20 ago 2026, 20:06 UTC

Shares of Resmed Inc. are lower amid rising crude oil prices and increasing U.S. Treasury yields, reflecting broader market trends. No specific company news was identified.

19 ago 2026, 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18 ago 2026, 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17 ago 2026, 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14 ago 2026, 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13 ago 2026, 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12 ago 2026, 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11 ago 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 ago 2026, 20:02 UTC

Social Media
News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 ago 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 ago 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 ago 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 ago 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 ago 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3 ago 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

Confronto tra pari

Modifica del prezzo

ResMed Inc Previsione

Obiettivo di Prezzo

By TipRanks

5.22% in crescita

Previsioni per 12 mesi

Media 241.417 USD  5.22%

Alto 320 USD

Basso 213 USD

Basato su 15 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ResMed Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

15 ratings

5

Acquista

10

Mantieni

0

Vendi

Sentiment

By Acuity

110 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat